iMEAN
PrivateLast Round
Grant
Jul 9, 2020
Company Overview
iMEAN is a biotechnology company that provides R&D support services using digital organisms and mathematical modeling for the agriculture, industrial biotechnology, and healthcare sectors.
Sector
Frontier & Industrial Tech
Verticals
Biotechnology, ML Platforms, Drug Discovery, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
iMEAN Comparables
Compare iMEAN with similar companies based on industry and business-model similarity.
iMEAN Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jul 9, 2020 | ||||
| Accelerator | Sep 3, 2018 |
Key People
Founding team and executive leadership
iMEAN Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Région Occitanie | Grant |
| French Ministry of the Economy, Finance and Industrial and Digital Sovereignty | Grant |
| Bpifrance | Grant |
| Nubbo | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 25, 2026
Grew 18% QoQ, from 17 to 20 employees.
- Jul 9, 2020
Received grant funding from Bpifrance and other French entities.
iMEAN Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about iMEAN's valuation, stock price, and market status.